Frontiers in Hematology

Case Report

Accepted on 12 Feb 2026

From Static Diagnosis to Clonal Kinetics: A New Framework for Timing Allogeneic Stem Cell Transplantation in Patients with Bone Marrow Failure Syndromes—A Hypothesis-Generating Case Series

in Blood Cancer

na li
li huang

Frontiers in Hematology

Original Research

Published on 12 Feb 2026

Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia

in Blood Cancer

Gratial Theres Joseph
Sandeep Kumar Swain
Himanshu Dhanda
Neetu Kushwaha
Priti Kumari
Mahek Pravin Khushalani
Rakesh Kumar
Baseer Noor
Sufian Zaheer
Aditi Jain

Frontiers in Hematology

doi 10.3389/frhem.2026.1709697

437 views

Case Report

Accepted on 04 Feb 2026

A rapid response to Obinutuzumab and Venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases

in Blood Cancer

Emin Abdullayev
Markus Bieringer
Anna Ossami Saidy
Wolfgang Schneider
Bertram Glaß
Snjezana Janjetovic

Frontiers in Hematology

134 views

Case Report

Published on 04 Feb 2026

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

in Blood Cancer

Jiaxin Wu
Hongxiang Wang

Frontiers in Hematology

doi 10.3389/frhem.2026.1748301

443 views

Original Research

Published on 30 Jan 2026

Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation

in Blood Cancer

Vinny Lococo
Maire Okoniewski
Abdalla Shoaib
Leyla Shune
Sunil Abhyankar
Anurag Singh
Dennis Allin
Briha Ansari
Joseph McGuirk
Omar S. Aljitawi

Frontiers in Hematology

doi 10.3389/frhem.2026.1733667

1,080 views

Case Report

Accepted on 26 Jan 2026

Two cases of Idiopathic Plasmacytic Lymphadenopathy subtype of Idiopathic Multicentric Castleman Disease with xanthelasma palpebrum from a Canadian center

in Blood Cancer

Andrew Chen
Vivian Yin
Paula Blanco
Richard Crawford
Ryan Henrie
Stephen Parkin
Nasreen Khalil
Mollie Carruthers
Lu Zhang
Luke Chen

Frontiers in Hematology

345 views

Case Report

Published on 23 Jan 2026

Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma

in Blood Cancer

Guilherme Gasparini Spiandorelo
Ahmed Alnughmush
Olivia Crum
Dragan Jevremovic
J. C. Villasboas

Frontiers in Hematology

doi 10.3389/frhem.2025.1683981

974 views

Original Research

Published on 21 Jan 2026

Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia

in Blood Cancer

Muluken Megiso
Chidiebube Ugwu
Elvis Obomanu
Alankrita Taneja

Frontiers in Hematology

doi 10.3389/frhem.2025.1730554

748 views

Original Research

Published on 12 Jan 2026

Myeloma patients’ attitudes and perceived burden of treatment administration routes and locations: insights from a pan-European survey

in Blood Cancer

Eilidh M. Duncan
Silene ten Seldam
Xavier Leleu
Diane Loening-Martens
Charlotte Pawlyn
Séverine Wollenschneider
Katie Joyner
Kate Morgan

Frontiers in Hematology

doi 10.3389/frhem.2025.1699930

1,635 views

Review

Published on 07 Jan 2026

To treat or not to treat: a state-of-the-art overview of smoldering multiple myeloma

in Blood Cancer

Ayushi Garg
Srinivas Devarakonda

Frontiers in Hematology

doi 10.3389/frhem.2025.1706219

1,195 views

Case Report

Accepted on 28 Nov 2025

A Converging Pathology: Chediak-Higashi Syndrome and IEI-Associated Lymphoproliferative Disease. Case Report

in Blood Cancer

Carlos R Varón
Santiago Andrés Suárez-Gómez
Daniela Varón
Libelly Gomez Florez
Carolina Cortes
Elda Graciela Velez
Isabella Corona

Frontiers in Hematology

710 views

Brief Research Report

Published on 13 Nov 2025

Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma

in Blood Cancer

Catarina Fernandes
Rita Costa e Sousa
Pedro Santos
Cátia Almeida
Adriana Roque
Ana Luísa Pinto
Joaquim Monteiro
Anabela Neves
Maria João Ramos
Rita Coutinho

Frontiers in Hematology

doi 10.3389/frhem.2025.1702446

1,732 views

Review

Published on 11 Nov 2025

A focus on LBCL patients in partial remission in the CAR-T era

in Blood Cancer

Giuseppe Tarantini
Elena Arcuti
Caterina Buquicchio
Vera Carluccio
Gaetano De Santis
Candida Rosaria Germano
Mariangela Leo
Daria Carmela Loconte
Sonia Mallano
Rosanna Maria Miccolis

Frontiers in Hematology

doi 10.3389/frhem.2025.1675099

1,916 views

Case Report

Published on 10 Oct 2025

Case Report: Extramedullary plasmacytoma of the stomach: a rare manifestation of relapsed multiple myeloma

in Blood Cancer

Canan D. Dirican
Folasade Ajayi
Anas Al Mardini
Sneha Bijoy
Hamid Shaaban
Gunwant Guron

Frontiers in Hematology

doi 10.3389/frhem.2025.1655966

1,565 views

Systematic Review

Published on 02 Oct 2025

The role of interventional radiology in pain management for multiple myeloma: a literature review

in Blood Cancer

Atlee Witt
Saumya Aujla
Meaghan Dendy Case

Frontiers in Hematology

doi 10.3389/frhem.2025.1649720

2,227 views

Original Research

Published on 25 Sep 2025

H3K27me3 and HOXA9 expression predict prognosis in pediatric acute myeloid leukemia: an epigenetic-transcriptional correlation study

in Blood Cancer

Hironori Goto
Souichi Suenobu
Yuhki Koga
Shunsuke Yamamoto
Kentaro Nakashima
Utako Oba
Daiichiro Hasegawa
Ikuya Usami
Ayako Yamamori
Hiroshi Moritake

Frontiers in Hematology

doi 10.3389/frhem.2025.1668408

2,165 views
1 citation

Brief Research Report

Published on 25 Sep 2025

Real-world data of azacitidine for relapsed/refractory nodal T-follicular helper cell lymphoma in 11 patients

in Blood Cancer

Philipp Faustmann
Jan C. Schroeder
Andreas Riedel
Christian M. Schürch
Simon Killinger
Laurent Phely
Lucas Mix
Claudia Lengerke
Max-Felix Häring

Frontiers in Hematology

doi 10.3389/frhem.2025.1638236

1,909 views

Brief Research Report

Published on 23 Sep 2025

Real-world experience of venetoclax target dosing with concomitant posaconazole in adult patients with acute myeloid leukemia

in Blood Cancer

Tracelyn Freeman
Alma Habib
Ying Huang
Pooja S. Kumar
Allyson Waller
Megan Fleming
Kelsey McMillan
Natalia Hartzler
Gregory Behbehani
James S. Blachly

Frontiers in Hematology

doi 10.3389/frhem.2025.1664425

2,389 views

Original Research

Published on 12 Sep 2025

Immune profile focusing on B-cell activating factor in B-cell malignancies

in Blood Cancer

Nami Tagami
Junya Yamagishi
Wataru Fujii
Chizu Sanjoba
Yasuyuki Goto

Frontiers in Hematology

doi 10.3389/frhem.2025.1626886

1,809 views

Case Report

Published on 22 Aug 2025

Case report: A case of intravascular large B-cell lymphoma and related literature review

in Blood Cancer

Wen Zhou
Xiaojia Guo
Yang Liu
Xin Wang
Hongbin Zhang
Liansheng Zhang
Lijuan Li

Frontiers in Hematology

doi 10.3389/frhem.2025.1639726

1,793 views

Review

Published on 16 Jul 2025

The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?

in Blood Cancer

Nicolò Danesin
Giovanni Leone
Mattia D’Antiga
Marco Carraro
Greta Scapinello
Livio Trentin
Francesco Piazza

Frontiers in Hematology

doi 10.3389/frhem.2025.1624046

2,812 views

Case Report

Published on 15 Jul 2025

Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature

in Blood Cancer

Cheng Ai
Jianqiao Shentu
Hening Xu
Yongming Xia
Shiwei Duan

Frontiers in Hematology

doi 10.3389/frhem.2025.1527938

1,435 views

Brief Research Report

Published on 11 Jul 2025

The “added value” of enrolling hematological patients in clinical trials: a single-center experience

in Blood Cancer

Stefano Loiacono
Elisa Lucchini
Maria Chiara Rossetti
Clara Palmieri
Irina Cebulec
Riccardo Provasi
Martina Lena
Eleonora De Bellis
Chiara Roni
Francesco Zaja

Frontiers in Hematology

doi 10.3389/frhem.2025.1613099

1,481 views

Case Report

Published on 23 Jun 2025

Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa

in Blood Cancer

Lydia Lee
Emma Fosbury
Rakesh Popat
Kwee Yong
Ashutosh Wechalekar
Jeremy S. Brown
Jeffrey Huang
Sandy Mcbride
John R. Hurst

Frontiers in Hematology

doi 10.3389/frhem.2025.1502322

996 views

85 articles

articles

From Static Diagnosis to Clonal Kinetics: A New Framework for Timing Allogeneic Stem Cell Transplantation in Patients with Bone Marrow Failure Syndromes—A Hypothesis-Generating Case Series

Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia

A rapid response to Obinutuzumab and Venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation

Two cases of Idiopathic Plasmacytic Lymphadenopathy subtype of Idiopathic Multicentric Castleman Disease with xanthelasma palpebrum from a Canadian center

Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma

Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia

Myeloma patients’ attitudes and perceived burden of treatment administration routes and locations: insights from a pan-European survey

To treat or not to treat: a state-of-the-art overview of smoldering multiple myeloma

A Converging Pathology: Chediak-Higashi Syndrome and IEI-Associated Lymphoproliferative Disease. Case Report

Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma

A focus on LBCL patients in partial remission in the CAR-T era

Case Report: Extramedullary plasmacytoma of the stomach: a rare manifestation of relapsed multiple myeloma

The role of interventional radiology in pain management for multiple myeloma: a literature review

H3K27me3 and HOXA9 expression predict prognosis in pediatric acute myeloid leukemia: an epigenetic-transcriptional correlation study

Real-world data of azacitidine for relapsed/refractory nodal T-follicular helper cell lymphoma in 11 patients

Real-world experience of venetoclax target dosing with concomitant posaconazole in adult patients with acute myeloid leukemia

Immune profile focusing on B-cell activating factor in B-cell malignancies

Case report: A case of intravascular large B-cell lymphoma and related literature review

The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?

Co-occurrence of AIDS and acute promyelocytic leukemia: a case report and review of the literature

The “added value” of enrolling hematological patients in clinical trials: a single-center experience

Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa